Your browser doesn't support javascript.
loading
Circulating levels of interleukin 6 soluble receptor and its natural antagonist, sgp130, and the risk of myocardial infarction.
Moreno Velásquez, Ilais; Golabkesh, Zahra; Källberg, Henrik; Leander, Karin; de Faire, Ulf; Gigante, Bruna.
Afiliação
  • Moreno Velásquez I; Unit of Cardiovascular Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Sweden.
  • Golabkesh Z; Unit of Cardiovascular Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Sweden.
  • Källberg H; Unit of Cardiovascular Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Sweden.
  • Leander K; Unit of Cardiovascular Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Sweden.
  • de Faire U; Unit of Cardiovascular Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Sweden; Dept of Cardiology, Karolinska University Hospital, Sweden.
  • Gigante B; Unit of Cardiovascular Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Sweden; Division of Cardiovascular Medicine, Dept of Clinical Sciences, Danderyd University Hospital Stockholm, Sweden. Electronic address: Bruna.Gigante@ki.se.
Atherosclerosis ; 240(2): 477-81, 2015 Jun.
Article em En | MEDLINE | ID: mdl-25910182
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores de Interleucina-6 / Receptor gp130 de Citocina / Infarto do Miocárdio Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores de Interleucina-6 / Receptor gp130 de Citocina / Infarto do Miocárdio Idioma: En Ano de publicação: 2015 Tipo de documento: Article